Global Cancer Registry Software, A Computerized Database that Stores Information on Cancer Patients - Market Analysis 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Global Cancer Registry Software Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Cancer Registry Software market is expected to reach $112.5 million by 2026 growing at a CAGR of 11.2% during 2018 to 2026. A cancer registry is a computerized database that uses software solutions to arrange, collect, and store data on cancer patients to assess cancer-specific outcomes, conditions, and drug/medical device exposure. These solutions help store, manage, and provide access to information that helps in building a cancer patient registry. Factors such as growing prevalence of cancer & favourable government initiatives and growing adoption of EHRs are fueling the market growth. Though, privacy and data security-related concerns are restraining the market growth.

By Type, Standalone Software segment has steady growth due to it provides useful and easy-to-use tools to store and process registry data and it offers advanced flexibility and features such as multiple system usage and automatic upgradation.

The key vendors mentioned are Mckesson Corporation, Rocky Mountain Cancer Data Systems, C/Net Solutions and Elekta AB (PUB).

Deployment Models Covered:

  • Cloud-Based Models
  • On-Premise Models

Database Types Covered:

  • Public Databases
  • Commercial Databases

Types Covered:

  • Integrated Software
  • Standalone Software

Functionalities Covered:

  • Patient Care Management
  • Product Outcome Evaluation
  • Medical Research & Clinical Studies
  • Cancer Reporting to Meet State and Federal Regulations

End Users Covered:

  • Hospitals & Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Cancer Research Centers
  • Government Organizations & Third-Party Administrators
  • Other End Users

Regions Covered:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Key Questions Answered in this Report:

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Cancer Registry Software Market, By Deployment Model

5.1 Introduction

5.2 Cloud-Based Models

5.3 On-Premise Models

6 Global Cancer Registry Software Market, By Database Type

6.1 Introduction

6.2 Public Databases

6.3 Commercial Databases

7 Global Cancer Registry Software Market, By Type

7.1 Introduction

7.2 Integrated Software

7.3 Standalone Software

8 Global Cancer Registry Software Market, By Functionality

8.1 Introduction

8.2 Patient Care Management

8.3 Product Outcome Evaluation

8.4 Medical Research & Clinical Studies

8.5 Cancer Reporting to Meet State and Federal Regulations

9 Global Cancer Registry Software Market, By End User

9.1 Introduction

9.2 Hospitals & Medical Practices

9.3 Private Payers

9.4 Pharmaceutical, Biotechnology, and Medical Device Companies

9.5 Cancer Research Centers

9.6 Government Organizations & Third-Party Administrators

9.7 Other End Users

10 Global Cancer Registry Software Market, By Geography

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 South America

10.5 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape

12.1 Mckesson Corporation

12.2 Rocky Mountain Cancer Data Systems

12.3 C/Net Solutions

12.4 Elekta AB (PUB)

For more information about this report visit https://www.researchandmarkets.com/r/dlpjtn

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Software, Healthcare Analytics , Oncology

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Software, Healthcare Analytics , Oncology